fluorobenzenes has been researched along with Albuminuria in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnaoutoglou, EM; Kouvelos, GN; Matsagkas, MI; Milionis, HJ; Papa, N; Raikou, VD | 1 |
Ball, T; McCullough, PA | 1 |
Fiebeler, A; Haller, H; Luft, FC; Menne, J; Mervaala, EM; Muller, DN; Park, JK | 1 |
Ferdinand, KC | 1 |
Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
Dodiya, H; Goswami, SS; Jain, M | 1 |
D'Haese, P; Geryl, H; Verhulst, A | 1 |
Abe, M; Maruyama, N; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M | 1 |
De Buyzere, ML; Delanghe, JR; Fiers, T; Speeckaert, MM; Wehlou, CM | 1 |
Berne, C; Jørgensen, L; Sager, P; Siewert-Delle, A; Sorof, J | 1 |
Habibi, J; Hayden, MR; Morris, EM; Rehmer, N; Sowers, JR; Stump, CS; Wei, Y; Whaley-Connell, AT; Yaghoubian, JC | 1 |
Cooper, SA; DeMarco, VG; Hayden, MR; Lastra, G; Manrique, C; Nistala, R; Sowers, JR; Wei, Y; Westerly, B; Whaley-Connell, A; Wiedmeyer, C | 1 |
Andresen, BT; Cooper, SA; DeMarco, VG; Ferrario, C; Habibi, J; Hayden, MR; Karuparthi, PR; Nistala, R; Rehmer, N; Sowers, JR; Wei, Y; Whaley-Connell, A | 1 |
1 review(s) available for fluorobenzenes and Albuminuria
Article | Year |
---|---|
Statins for the prevention of contrast-induced acute kidney injury.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Albuminuria; Contrast Media; Coronary Angiography; Creatinine; Diabetes Complications; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Kidney Tubules; Lipoproteins; Meta-Analysis as Topic; Muscle Cells; Percutaneous Coronary Intervention; Pyrimidines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renal Replacement Therapy; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides | 2014 |
4 trial(s) available for fluorobenzenes and Albuminuria
Article | Year |
---|---|
The effect of adding ezetimibe to rosuvastatin on renal function in patients undergoing elective vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol, LDL; Dyslipidemias; Elective Surgical Procedures; Ezetimibe; Female; Fluorobenzenes; Glomerular Filtration Rate; Greece; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Vascular Surgical Procedures | 2015 |
No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.
Topics: Adult; Aged; Albuminuria; Cross-Over Studies; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Proteinuria; Proteome; Proteomics; Pyrimidines; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides; Two-Dimensional Difference Gel Electrophoresis | 2011 |
Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Blood Pressure; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cystatin C; Diabetic Nephropathies; Female; Fluorobenzenes; Glycemic Index; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Kidney Function Tests; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2011 |
Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients.
Topics: Aged; Albuminuria; Atorvastatin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorobenzenes; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Male; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2006 |
8 other study(ies) available for fluorobenzenes and Albuminuria
Article | Year |
---|---|
Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Collagen Type IV; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Fluorescent Antibody Technique, Indirect; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Cortex; Kidney Medulla; Male; Monocytes; Necrosis; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Rosuvastatin Calcium; Sulfonamides | 2009 |
Achieving treatment goals in low-risk, asymptomatic patients.
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Black or African American; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Female; Fluorobenzenes; Health Status Indicators; Humans; Hypolipidemic Agents; Metabolic Syndrome; Middle Aged; Obesity; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; United States | 2010 |
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Renal toxicity of lisinopril and rosuvastatin, alone and in combination, in Wistar rats.
Topics: Acute Kidney Injury; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Clusterin; Drug Combinations; Female; Fluorobenzenes; Kidney Tubules, Proximal; Lisinopril; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides | 2011 |
α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients.
Topics: Adolescent; Adult; Aged; Albuminuria; Alpha-Globulins; Case-Control Studies; Cholesterol; Creatinine; Cystatin C; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Tubules; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2013 |
Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
Topics: Albumins; Albuminuria; Aminoquinolines; Animals; Blotting, Western; Cell Membrane; Cells, Cultured; Culture Media, Serum-Free; Disease Models, Animal; Endocytosis; Enzyme Activation; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules, Proximal; Microscopy, Confocal; NADPH Oxidases; Opossums; Oxidative Stress; Pyrimidines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Rosuvastatin Calcium; Signal Transduction; Sulfonamides | 2007 |
Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Fluorobenzenes; Glomerular Filtration Rate; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Microscopy, Electron, Transmission; Obesity; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase | 2008 |
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cell Line, Transformed; Enzyme Activation; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Kidney Cortex; Kidney Glomerulus; Male; Mice; Microscopy, Electron; NADPH Oxidases; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Rosuvastatin Calcium; Sulfonamides | 2008 |